Cargando…
Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study
INTRODUCTION: Sepsis is the leading cause of acute kidney injury (AKI) in critically ill patients. The Kidney in Sepsis and Septic Shock (Kid-SSS) study evaluated the value of proenkephalin A 119-159 (penkid)—a sensitive biomarker of glomerular function, drawn within 24 hours upon intensive care uni...
Autores principales: | Hollinger, Alexa, Wittebole, Xavier, François, Bruno, Pickkers, Peter, Antonelli, Massimo, Gayat, Etienne, Chousterman, Benjamin Glenn, Lascarrou, Jean-Baptiste, Dugernier, Thierry, Di Somma, Salvatore, Struck, Joachim, Bergmann, Andreas, Beishuizen, Albertus, Constantin, Jean-Michel, Damoisel, Charles, Deye, Nicolas, Gaudry, Stéphane, Huberlant, Vincent, Marx, Gernot, Mercier, Emanuelle, Oueslati, Haikel, Hartmann, Oliver, Sonneville, Romain, Laterre, Pierre-François, Mebazaa, Alexandre, Legrand, Matthieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224621/ https://www.ncbi.nlm.nih.gov/pubmed/30450469 http://dx.doi.org/10.1016/j.ekir.2018.08.006 |
Ejemplares similares
-
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study
por: Mebazaa, Alexandre, et al.
Publicado: (2018) -
Hollinger A, Wittebole X, François B, et al. Proenkephalin A 119-159 (Penkid) is an early biomarker of septic acute kidney injury: the Kidney in Sepsis and Septic Shock (Kid-SSS) Study. Kidney Int Rep. 2018;3:1424–1433
Publicado: (2018) -
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study
por: Blet, Alice, et al.
Publicado: (2021) -
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial
por: Laterre, Pierre-François, et al.
Publicado: (2021) -
Proenkephalin a 119–159 (penKid) – a novel biomarker for acute kidney injury in sepsis: an observational study
por: Rosenqvist, Mari, et al.
Publicado: (2019)